Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

INVESTIGATION NOTICE: Kaskela Law LLC Announces Stockholder Investigation of Dentsply Sirona Inc. (XRAY) and Encourages Long-Term XRAY Investors to Contact the Firm

XRAY

Philadelphia, Pennsylvania--(Newsfile Corp. - November 19, 2024) - Kaskela Law LLC announces that it is investigating Dentsply Sirona Inc. (NASDAQ: XRAY) ("Dentsply") on behalf of the company's long-term stockholders.

Click here for additional information: https://kaskelalaw.com/case/dentsply-sirona/

Recently an amended securities fraud complaint was filed against Dentsply on behalf of investors who purchased shares of the company's stock between June 9, 2021 and November 13, 2022. According to the complaint, during that time period Dentsply and certain of the company's senior executive officers materially misrepresented the company's financial and operational results for the second half of fiscal 2021 by engaging in "channel stuffing," "off-book arrangements," "enhanced incentives" to end-users, and the delayed issuance of rebate checks.

The complaint further details how, through a series of partial disclosures between April 2022 and November 2022 - which included resignations, terminations, and an internal investigation by the company's Audit and Finance Committee - investors slowly learned the truth about the company's prior misrepresentations and suffered economic damages as a result therefrom. During that time period, the company's stock price declined in value from approximately $48.00 per share in April 2022 to approximately $30.00 per share in November 2022.

The investigation seeks to determine whether the members of Dentsply's board of directors violated the securities laws and/or breached their fiduciary duties in connection with the above alleged misconduct and disclosures.

Dentsply stockholders who purchased or acquired shares of XRAY stock prior to April 11, 2022 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 - 0750 for additional information about this investigation and their legal rights and options. Alternatively, investors may submit their information to the firm by clicking on the following link (or by copying and pasting the link into your browser):

https://kaskelalaw.com/case/dentsply-sirona/

CONTACT:

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
(484) 229 - 0750
www.kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/230493



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today